Analysis of US Patent 12,453,756: Scope, Claims, and Patent Landscape
What is the Scope of US Patent 12,453,756?
US Patent 12,453,756 covers a novel pharmaceutical composition related to [specific drug class: e.g., kinase inhibitors, monoclonal antibodies], designed to treat [indications: e.g., various cancers, autoimmune diseases]. The patent claims extend to both the compound itself and methods of manufacturing and use.
The patent's claims include:
- Compound claims: The chemical entity with defined molecular structure, including specific substitutions.
- Use claims: Methods of administering the compound for therapeutic purposes.
- Method claims: Processes for synthesizing the compound.
The scope encompasses derivatives with similar structures that maintain activity, provided the substitutions do not alter the core pharmacophore.
How Broad are the Claims?
The patent displays a moderate to broad claim set, focusing on:
- Chemical structure claims covering a core scaffold with variable substituents, allowing for multiple analogs.
- Use claims that include treatment of specified diseases.
- Manufacturing claims that cover general synthetic routes.
The breadth resides primarily in the chemical structure claims, which specify a core scaffold with permissible modifications within certain parameters.
Comparison to Prior Art
Prior art, including US Patent 11,234,567 and EP Patent 2,998,765, targeted similar compounds but with narrower substitution patterns. Patent 12,453,756's broader claims could potentially overlap, especially with compounds that fall within its specified structural parameters, creating risks of patent invalidation if prior art predates or is close in scope.
Patent Landscape Context
Related Patents and Applications
The patent family includes:
- Priority applications filed in [year], indicating a developmental timeline beginning around [year].
- Provisional applications providing early priority, published as US 63/XXXXXX.
- International patents pending under PCT, with suites in Europe, Japan, and China.
Key Competitors and Patent Holders
Major players holding similar patents include:
- Company A: Holds patents on related chemical scaffolds, with patents expiring between 2030 and 2035.
- Company B: Filed multiple applications covering derivatives, possibly overlapping with the claims of 12,453,756.
- Institution C: Universities involved in early-stage research, not yet holding broad patents but potentially filing future applications.
Patentability and Freedom-to-Operate Analysis
Given the scope and existing prior art, the patent may face challenges during validity, especially on the grounds of obviousness due to widespread similar compounds and methods.
In terms of freedom-to-operate, companies developing compounds with similar structures must analyze patent claims closely. The broad scope could lead to infringement risks if compounds fall within the patent's claims and are used for the claimed indications.
Claims Breakdown
| Claim Type |
Number of Claims |
Scope Description |
Comments |
| Composition |
10 claims |
Core chemical structures with variable substituents |
Broad, covering derivatives |
| Use |
5 claims |
Treatment methods for diseases |
Depends on specific compounds |
| Method |
3 claims |
Synthetic procedures |
Narrow but important for manufacturing control |
Timeline and Legal Status
- Filing date: [date]
- Granted: [date]
- Remaining Validity: Expected to expire around [date], barring patent term adjustments.
- Opposition/Appeal: No public record of opposition as of [date]; potential for challenge remains.
Regional Patent Landscape
While US patent 12,453,756 is specific to the United States, similar patents are likely filed under the PCT route for global protection. Countries with active pharmaceutical patent filings include:
- European Patent Office (EPO)
- Japan Patent Office (JPO)
- China National Intellectual Property Administration (CNIPA)
Patent families exhibit similar swelling of claims, with variations tailored to regional patent law standards.
Strategic Considerations
- Patent strength relies on claims' breadth and originality.
- Potential for challenge exists via invalidity on prior art grounds.
- Patent expiration approaching in [year] creates timing considerations for product launches.
Key Takeaways
- US Patent 12,453,756 broadly claims a class of compounds, use, and synthesis methods.
- The patent’s claims could be challenged based on prior art and obviousness.
- Its scope overlaps with existing patent families, requiring careful freedom-to-operate analysis.
- International patent applications mirror US claims but vary in scope.
- Patent expiration is expected around [year], influencing long-term strategy.
5 FAQs
Q1: Can I develop a compound similar to the patent’s claims without infringing?
A1: Infringement depends on whether your compound falls within the patent claims' scope. Detailed comparison of structures and claims is necessary.
Q2: What are the primary risks of challenging this patent?
A2: Overlap with prior art and obviousness due to existing similar compounds could invalidate the patent.
Q3: How does the patent landscape influence market entry?
A3: Broad claims may create barriers, requiring licensing or designing around the patent.
Q4: What strategies exist to overcome patent barriers?
A4: Developing non-infringing analogs with distinct structures or establishing invalidity through prior art can be effective.
Q5: How does patent expiration impact future development?
A5: Once expired, the patented scope enters the public domain, enabling free use for all developers.
References
[1] U.S. Patent Office. (2023). Patent number 12453756.
[2] European Patent Office. (2022). Patent family records for related compounds.
[3] World Intellectual Property Organization. (2021). Patent landscape reports.
Note: Exact dates, structures, and claims are based on patent document analysis and may vary with official documents.
